AAAAAA
Results:
1-8
|
Results: 8
Authors:
Bergquist, A
Glaumann, H
Stal, P
Wang, GS
Broome, U
Citation: A. Bergquist et al., Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma, J INTERN M, 249(1), 2001, pp. 69-75
Authors:
Fleming, KA
Boberg, KM
Glaumann, H
Bergquist, A
Smith, D
Clausen, OPF
Citation: Ka. Fleming et al., Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis, J HEPATOL, 34(3), 2001, pp. 360-365
Authors:
Bergquist, A
Tribukait, B
Glaumann, H
Broome, U
Citation: A. Bergquist et al., Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis?, J HEPATOL, 33(6), 2000, pp. 873-877
Authors:
Wejstal, R
Fischler, B
Glaumann, H
Norkrans, G
Reichard, O
Sonnerborg, A
Uhnoo, I
Weiland, O
Citation: R. Wejstal et al., Chronic hepatitis C - Swedish experts' meeting recommends combination treatment, SC J IN DIS, 32(5), 2000, pp. 465-470
Authors:
Halasz, R
Sallberg, M
Lundholm, S
Andersson, G
Lager, B
Glaumann, H
Weiland, O
Citation: R. Halasz et al., The GB virus C/hepatitis G virus replicates in hepatocytes without causingliver disease in healthy blood donors, J INFEC DIS, 182(6), 2000, pp. 1756-1760
Authors:
Schvarcz, R
Glaumann, H
Reichard, O
Weiland, O
Citation: R. Schvarcz et al., Histological and virological long-term outcome in patients treated with interferon-alpha 2b and ribavirin for chronic hepatitis C, J VIRAL HEP, 6(3), 1999, pp. 237-242
Authors:
Lindblad, A
Glaumann, H
Strandvik, B
Citation: A. Lindblad et al., Natural history of liver disease in cystic fibrosis, HEPATOLOGY, 30(5), 1999, pp. 1151-1158
Authors:
Reichard, O
Glaumann, H
Fryden, A
Norkrans, G
Wejstal, R
Weiland, O
Citation: O. Reichard et al., Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon, J HEPATOL, 30(5), 1999, pp. 783-787
Risultati:
1-8
|